Research And Development
Technology
Manufacturing

Agilent

$81.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (0.28%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Agilent and other stocks, options, ETFs, and crypto commission-free!

About

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab. Read More The Life Sciences & Applied Markets Business segment offers application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The Diagnostics & Genomics segment is comprised of five areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its consumables and services portfolio, which is designed to improve customer outcomes. The company was founded on May 1999 and is headquartered in Santa Clara, CA.

Employees
14,800
Headquarters
Santa Clara, California
Founded
1999
Market Cap
25.75B
Price-Earnings Ratio
23.00
Dividend Yield
0.92
Average Volume
2.48M
High Today
$81.77
Low Today
$81.03
Open Price
$81.10
Volume
390.93K
52 Week High
$81.77
52 Week Low
$60.42

Collections

Research And Development
Technology
Manufacturing
Chemicals
Software Service
Biotechnology

News

PR NewswireMar 18

Worldwide Genomics Market Outlook, 2019 to 2024 - Thermo Fisher Scientific, Illumina, QIAGEN, and Agilent Technologies are Dominating

DUBLIN, March 18, 2019 /PRNewswire/ -- The "Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024" report has been added to ResearchAndMarkets.

29
TradingNewsNowMar 18

Valuation Today: Agilent Technologies (NYSE: A)

Agilent Technologies trades as part of the medical diagnostics and research industry and healthcare sector. The company CEO is Michael R. McMullen. Agilent Technologies Inc is engaged in life sciences, diagnostics and applied chemical markets. The company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Previous Intraday Trading Performance: The A stock showed a previous change of 0.61% with an open at 80.86 and a close...

9
MarketWatchMar 15

Agilent Technologies Inc.

Agilent Technologies Inc. Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab. The Life Sciences & Applied Markets Business segment offers application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and ...

28

Earnings

$0.52
$0.62
$0.71
$0.81
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected May 13, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.